ARK Invest released a comprehensive report detailing Bitcoin’s milestones in 2024, the surging run of AI agents, and the ...

In fact, investors committed to a Cathie Wood-backed ETF will find that they're out of luck since Ark Invest ETFs don't pay dividends. Whether you're considering an ETF or a mutual fund (or ...

Cathie Wood's Ark Invest has destroyed $14 billion in wealth over the past decade. A Morningstar analysis found that Ark ...

ARKK, the flagship fund of Ark Invest, has removed 187,968 shares of Palantir Technologies throughout January 2022. PLTR continues to be ARKK's fifth-largest holding with a market value at $351.9 ...

The ARK ETFs are off to another great start in 2021, but the top performer is one of its lesser-known funds. ARK Invest has become ... so far in 2021. In fact, none of them have close to keep ...

Ark Invest purchased shares of CRISPR Therapeutics AG for both its ARK Genomic Revolution ETF ARKG and Ark Innovation ETF ARKK. The ARKG ETF bought 43,467 shares, while the ARKK ETF acquired ...

In today’s Daily Dive, we’re highlighting the latest ARK Invest Bitcoin white paper, “On-Chain Data: A Framework To Evaluate Bitcoin.” The paper was authored by Yassine Elmandjra, analyst at ARK ...

Palantir (NASDAQ:PLTR) shares slipped 5% by noon trading on Tuesday after Cathie Wood's ARK Invest ETFs sold off $15M in shares. Palantir shares skyrocketed more than 330% during 2024, but have ...

Tesla (TSLA) stock is down more than 30% so far in 2024, but Ark Invest CEO Cathie Wood thinks "now is not the time to run for the hills." In fact, Ark has been buying the stock and thinks it ...

Cathie Wood’s asset management firm, Ark Invest, has once again offloaded shares of EV giant Tesla (TSLA). According to the most recent trading statement, 152,694 shares of Tesla were sold ...

IND), amid a ~$15M stake sale from ARK Invest. After a series of similar sales over the past two months, does Cathie Wood-led investment firm’s latest decision to offload roughly 196.7K shares ...

Ark Invest’s ARK Innovation ETF ARKK purchased a substantial 264,596 shares of Recursion Pharmaceuticals. The value of this trade, calculated from the closing price of $6.88, is approximately $1 ...